Commonwealth Equity Services’s HTG Molecular Diagnostics HTGM Stock Holding History
Bought
Maintained
Sold
Other funds holding HTGM
SC
Commonwealth Equity Services's HTGM Position: Q4 2020 in Review
Commonwealth Equity Services sold out of HTG Molecular Diagnostics (HTGM) in Q4 2020, closing a stake of 212 shares — an estimated $12K sold.
Commonwealth Equity Services first reported a position in HTGM in Q3 2017 and held it in 10 quarters. The position peaked at $141K in Q3 2018. 23 funds tracked by Wall St. Rank hold HTGM as of Q4 2020.
- Commonwealth Equity Services reported no remaining HTG Molecular Diagnostics position as of Q4 2020 after selling out during the quarter.
- Commonwealth Equity Services sold 212 HTG Molecular Diagnostics shares in Q4 2020, an estimated $12K.
- Commonwealth Equity Services first reported a position in HTG Molecular Diagnostics in Q3 2017 and held it in 10 quarters.
- Commonwealth Equity Services's HTG Molecular Diagnostics position peaked at $141K in Q3 2018.
- 23 funds tracked by Wall St. Rank held HTG Molecular Diagnostics as of Q4 2020.
Based on Commonwealth Equity Services's 13F filing for Q4 2020, filed 11 Feb 2021.